Literature DB >> 15461925

Overview of Pediatric Headache.

Paul Winner1.   

Abstract

There is a high prevalence of headache disorders in children and adolescents. Headache in pediatric population is substantially underdiagnosed and undertreated. The recently revised International Headache Society criteria are a step in the right direction to improve our diagnostic accuracy. The recent increases in evidence-based data in the pediatric headache population will help to outline appropriate management strategies for acute and preventive treatment. In this article, diagnostic and treatment issues related to the pediatric headache patient will be reviewed.

Entities:  

Year:  2004        PMID: 15461925     DOI: 10.1007/s11940-004-0005-8

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  52 in total

1.  Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults?

Authors:  M L Hämäläinen; K Hoppu; P Santavuori
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

2.  Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies.

Authors:  R Ryan; A Elkind; C C Baker; W Mullican; S DeBussey; M Asgharnejad
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

3.  Migraine and muscle contraction headaches: a continuum.

Authors:  H J Featherstone
Journal:  Headache       Date:  1985-06       Impact factor: 5.887

4.  Subcutaneous sumatriptan in the clinical setting: the first 50 consecutive patients with acute migraine in a pediatric neurology office practice.

Authors:  S L Linder
Journal:  Headache       Date:  1996 Jul-Aug       Impact factor: 5.887

5.  Factors of early life as predictors of headache in children at school entry.

Authors:  M Aromaa; P Rautava; H Helenius; M L Sillanpää
Journal:  Headache       Date:  1998-01       Impact factor: 5.887

6.  Flunarizine v. placebo in childhood migraine. A double-blind study.

Authors:  F Sorge; E Marano
Journal:  Cephalalgia       Date:  1985-05       Impact factor: 6.292

7.  The calcium antagonist properties of cyproheptadine: implications for antimigraine action.

Authors:  S J Peroutka; G S Allen
Journal:  Neurology       Date:  1984-03       Impact factor: 9.910

Review 8.  Migraine headache: epidemiologic perspectives.

Authors:  M S Linet; W F Stewart
Journal:  Epidemiol Rev       Date:  1984       Impact factor: 6.222

9.  Epidemiology of headache and childhood migraine in an urban general practice using Ad Hoc, Vahlquist and IHS criteria.

Authors:  M J Mortimer; J Kay; A Jaron
Journal:  Dev Med Child Neurol       Date:  1992-12       Impact factor: 5.449

10.  Diagnoses and symptom patterns in children presenting to a pediatric headache clinic.

Authors:  J Gladstein; E W Holden; L Peralta; M Raven
Journal:  Headache       Date:  1993-10       Impact factor: 5.887

View more
  3 in total

Review 1.  The efficacy of triptans in childhood and adolescence migraine.

Authors:  Stefan Evers
Journal:  Curr Pain Headache Rep       Date:  2013-07

Review 2.  Controlled trials in pediatric migraine: crossover versus parallel group.

Authors:  Stefan Evers
Journal:  Curr Pain Headache Rep       Date:  2007-06

3.  Effective dose of topiramate in pediatric migraine prophylaxis.

Authors:  Ali Abbaskhanian; Hamid Reza Sadeghi; Ali Erfani; Mohammad Sadegh Rezai
Journal:  J Pediatr Neurosci       Date:  2012-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.